About 4basebio
Conventional fermentation-based DNA production methods are very costly and the DNA yield during production is relatively low, which is one of the factors contributing to the very high cost of gene therapies.
4basebio has recognized the ever-increasing global need for high-purity, pharmaceutical-grade DNA. The company's proprietary enzymatic technologies are being used to develop processes that can produce DNA completely synthetically in large quantities with minimal effort.
4basebio's goal is to significantly reduce the cost of gene therapies and to offer these innovative and in many cases vital therapies to more patients globally.
By expanding its proprietary technologies around the production of pharmaceutical DNA, 4basebio aims to become a key partner to the global pharmaceutical industry in the mass production of gene therapies and DNA vaccines.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of 4basebio
Here you will find 4basebio AG
See the theme worlds for related content
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
